Keeping up with the market is hard enough without a looming global pandemic swinging it out of control. Although it is difficult to stay on top of recent trends, it is essential if you want to stay ahead of the market and your competition. Continually tracking trends, identifying who is doing well and why, along
Catalyst OrthoScience Inc., a medical device company focused on the upper extremity orthopedics market, has received clearance from the U.S. Food & Drug Administration (FDA) to market its reverse shoulder system. Catalyst’s reverse shoulder system is a single-tray arthroplasty system that is made to combine beneficial and evidence-based attributes of reverse shoulder arthroplasty design. The
Did you know there are over 8.9 million orthopedic procedures performed in the United States each year, with the orthopedic biomaterials market showing the greatest forecast growth? As this market continues to grow and innovative technologies are being designed, we have compiled a list of the top companies within different categories of the orthopedics market including: Orthopedic
The growing elderly demographic has been a considerable market driver within the orthopedic biomaterials market, the incidence of osteoarthritis and other forms of degenerative diseases have also been on the rise. In an effort to find a cure for such diseases researchers have been investigating the abilities of smart biomaterials. Smart biomaterials autonomously respond to
Zimmer Biomet’s Bactiguard-coated orthopedic trauma implants have recently received European regulatory clearance and CE mark. Preparations for registering the implants in the U.S. market are also ongoing. The Bactiguard technology was originally developed by the Swedish medical device company, which goes by the same name. The company focuses on developing solutions that reduce the risk
DePuy Synthes has recently announced they received 510(k) FDA Clearance for VELYS, a robotic-assisted system designed for use with the Attune total knee system. DePuy Synthes has described the Velys platform as a first-of-its-kind, table-mounted solution with an efficient design capable of integrating into any operating room. The company said it adapts to a surgeon’s
The U.S. Food and Drug Administration recently granted marketing authorization for an anterior cruciate ligament (ACL) implant, intended to perform as an alternative to traditional ACL reconstructions. The Bridge-Enhanced ACL Repair (BEAR) Implant, by Miach Orthopaedics, differs from the traditional surgical reconstruction as it does not require the use of harvested tendons for ACL repair
Medtronic has announced that the U.S. Food and Drug Administration (FDA) has cleared the use of navigated interbody high-speed drills with the Robotic Guidance System. Even in the midst of the COVID19 pandemic the company has received the clearance earlier than anticipated. This system now integrates the surgical planning software with robotic guidance. Spinal instruments
Stryker has announced it has cleared all regulatory hurdles previously in the way of its planned $4.7 billion acquisition of Wright Medical. The tender offer was initiated back in November 2019 and has now been completed as of November 11, 2020. “Wright Medical has built a successful business, and together we look forward to working
Anika Therapeutics, Inc. announced that the WristMotion Total Arthroplasty System received 510(k) clearance from the U.S. Food and Drug Administration. The WristMotion System is used in procedures to replace painful wrist joints due to rheumatoid arthritis, osteoarthritis, or post-traumatic arthritis, allowing a patient to maintain native biomechanics. This replacement implant is an entirely new approach
